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Abstract
Aims: The purpose of this multi-phase explorative in vivo animal/surgical and
in vitro multi-test experimental study was to (1) create a 3 wt%nanostrontium hydroxyapatite-enhanced calcium phosphate cement (SrHA/CPC) for increasing bone formation and (2) creating a simvastatin-loaded
poly(lactic-co-glycolic acid) (SIM-loaded PLGA) microspheres plus CPC
composite (SIM-loaded PLGA + nanostrontium-CPC). The third goal was the
extensive assessment of multiple in vitro and in vivo characteristics of the
above experimental explorative products in vitro and in vivo (animal and
surgical studies).
Methods and results pertaining to Sr-HA/CPC: Physical and chemical
properties of the prepared Sr-HA/CPC were evaluated. MTT assay and alkaline
phosphatase activities, and radiological and histological examinations of SrHA/CPC, CPC and negative control were compared. X-ray diffraction (XRD)
indicated that crystallinity of the prepared cement increased by increasing the
powder-to-liquid ratio. Incorporation of Sr-HA into CPC increased MTT assay
(biocompatibility) and ALP activity (P < 0.05). Histomorphometry showed
greater bone formation after 4 weeks, after implantation of Sr-HA/CPC in 10
rats compared to implantations of CPC or empty defects in the same rats
(n = 30, ANOVA P < 0.05).
Methods and results pertaining to SIM-loaded PLGA
microspheres + nanostrontium-CPC composite: After SEM assessment,
the produced composite of microspheres and enhanced CPC were implanted
for 8 weeks in 10 rabbits, along with positive and negative controls, enhanced
CPC, and enhanced CPC plus SIM (n = 50). In the control group, only a small
amount of bone had been regenerated (localized at the boundary of the
defect); whereas, other groups showed new bone formation within and
around the materials. A significant difference was found in the osteogenesis
induced by the groups sham control (16.96 ± 1.01), bone materials
(32.28 ± 4.03), nanostrontium-CPC (24.84 ± 2.6), nanostrontium-CPCsimvastatin (40.12 ± 3.29), and SIM-loaded PLGA + nanostrontium-CPC
(44.8 ± 6.45) (ANOVA P < 0.001). All the pairwise comparisons were
significant (Tukey P < 0.01), except that of nanostrontium-CPC-simvastatin
and SIM-loaded PLGA + nanostrontium-CPC. This confirmed the efficacy of
the SIM-loaded PLGA + nanostrontium-CPC composite, and its superiority
over all materials except SIM-containing nanostrontium-CPC.
Keywords: Biomaterials, Drug delivery systems, Calcium phosphate cement
(CPC), Strontium, Hydroxyapatite, Brushite, Bone formation, Simvastatin,
Poly(lactic-co-glycolic acid) microspheres

1. Introduction
In 1980s, calcium phosphate cements (CPCs) were discovered
by LeGeros and Chow et al.1 Calcium phosphate cements are used as
the bone substitute materials and can serve as injectable pastes to fill
defects, while being biocompatible and osteoconductive.2,3 A bioactive
material is one that can bind with the surrounding bone without the
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formation of fibrous tissue.4 Bioactivity, together with the perfect
adaptability of the cement paste leads to a stable connection between
defect and implant and boost bone healing process.5,6 The main
reaction of calcium phosphate cements is the cementing action of
acidic and basic calcium phosphate compounds in an aqueous
solution.1,2,7 Calcium phosphate cements are formed by a chemical
reaction between two phases: the dry powder phase which is a
combination of calcium orthophosphate, and the liquid phase which is
water or a calcium or phosphate-containing aqueous solution.1,2,4,7,8
After mixing the powder phase with the liquid phase, a paste forms
that sets and hardens into a solid mass. One of the advantages of
calcium phosphate cements is that no heat is generated during
cementation reaction and the cementation process is not exothermic
(thus, no risk of hyperthermia).2,3,7,9,10 Furthermore calcium phosphate
cements are intrinsically microporous, as a result of extra aqueous
solution leaving the material after hardening. This property can be
used for carrying of biological fluids into CPCs and causes degradation
and replacement of CPCs by bone. Degradation rate depends on the
composition and microstructure of the cement. Degradation products
are well absorbed by the surrounding tissues.11,12,13,14
Despite having many advantages, calcium phosphate cements
have some drawbacks including poor mechanical properties. Like most
ceramics, they are brittle. Furthermore, due to their intrinsic porous
structure, their strength is lower than acrylic cements. This drawback
has limited their application.11,15,16,17
There are two main calcium phosphate cements: hydroxyapatite
and dicalcium phosphate dehydrate (brushite). The final product
formed by the liquid and solid phase depends on pH of the solution.
Hydroxyapatite forms in pHs higher than 4.2 while brushite (DCPD)
forms when the pH is lower than 4.2. Solubility of brushite is greater
than hydroxyapatite at physiological pH. In fact brushite is metastable
under physiological conditions and can be resorbed more quickly than
hydroxyapatite.2,8,18
Brushite cements have generally short setting times (about 30
to 60 s) that limit their use as orthopedic applications. To make these
cements suitable for orthopedic usage, specific setting retardants
(such as pyrophosphate ions or citrates) are usually added to slow
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down the setting process by inhibiting nucleation and growth of
calcium phosphate crystals.7,16,19,20 Moreover, some ions like Sr, Zn,
and Mg can serve as enzyme cofactors in bone regeneration
process.21,22,23 Thus, the incorporation of these ions in biomaterials can
improve bone tissue healing.24,25
Strontium can stimulate osteoblast differentiation and inhibit
osteoclast activity and therefore is a valuable ion in treatment of
osteoporosis. Hence, there are interests in incorporating strontium in
calcium phosphate cements. Incorporation of strontium affects the
reactivity of the cement but can also modify the final composition of
the material.24,25,26
A recent advent in pharmacology is solid polymer biodegradable
particulates such as micro and sub-micron spheres with high
dissolution rates, which might be of use in locally targeted
pharmaceutical delivery and regeneration of injured tissues.27,28,29
Because of their biodegradation potential and physiological removal,
poly(lactic-co-glycolic acid) (PLGA) microspheres might be a proper
candidate for such drug delivery systems.28,30,31 Simvastatin (SIM) is a
hypolipidemic drug capable of inducing bone regeneration; hence it
might be loaded into PLGA microspheres to possibly improve stability
of microspheres after formation while also improving the bone
regeneration.28,32,33
In this study, the structural, physicochemical and biological
properties of the type of calcium phosphate cements modified by
strontium ion were evaluated. Also its effect on bone generation was
examined. Afterwards, a new form of SIM-PLGA was created by the
addition of nanostrontium-enhanced CPC. Its efficacy in improving
osteogenesis was assessed.

2. Materials and methods
2.1. Overview
In the first phase of this study (in vitro), an optimum ratio of
power to liquid (P/L) was selected (among three available ratios) for
producing 3 wt% nanostrontium-enhanced CPC with the best in vitro
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properties. The recommended ratio was then used in next phases: in
the second phase, the 3 wt% nanostrontium-enhanced CPC was
assessed with various in vitro biological tests and then was compared
against CPC as well as negative controls in rat. In the third phase (in
vitro), the nanostrontium-enhanced CPC was composited with
simvastatin-loaded poly(lactic-co-glycolic acid) (SIM-loaded PLGA)
microspheres. In the last phase the properties of this “SIM-loaded
PLGA + 3 wt% nanostrontium-enhanced CPC” composite biomaterial
was evaluated in vitro. Then efficacy of this composite material in
ontogenesis induction was evaluated in vivo (rabbit) against the
materials: 3 wt% nanostrontium-enhanced CPC and 3 wt%
nanostrontium-enhanced CPC plus simvastatin, a negative control
(sockets left empty after bone trephining) as well as a positive control
(experimental bone defects filled with the animal's trephined bone
transplanted from the negative control sites). This study was
conducted in accordance with the regulations and approval of the
Institutional Animal Care and Ethical Committee of the Tehran
University of Medical Sciences.

2.2. Preparation of nanostrontium-enhanced CPC
To prepare calcium phosphate cement powder in this research,
one gram of tetracalcium phosphate (Ca4P2O9, TTCP) with a controlled
mean particle size of 10 μm was synthesized following the method
from the reaction of dicalcium phosphate dihydrate (CaHPO4·2H2O,
DCPD; Merck Co. Kenilworth, New Jersey, United States) and calcium
carbonate (CaCO3). Afterwards, disodium hydrogen phosphate
(Na2HPO4; Merck) was added to the mixture; three different amounts
of Na2HPO4 were added, in order to create 3 different powder-to-liquid
ratios 1.205 ml (P/L = 0.83), 0.8 ml (P/L = 1.25), and 0.645 ml
(P/L = 1.55). Finally, 3 wt% of synthesized nanostrontium-substituted
hydroxyapatite (Sr-HA) (10% of calcium in hydroxyapatite was
replaced with strontium) was added to the prepared cement. The
calcium phosphate cement powder was mechanically ground to the
mean particle size distribution of 3 mm; then it was vacuum-packed
and g-ray-sterilized (20 kGy). The size of nanoparticles is evident in
Fig. 1.
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Fig. 1. Transmission electron micrograph of the synthetized nanostrontium
hydroxyapatite.

2.3. Characterization of nanostrontium-enhanced CPC
2.3.1. X-ray diffraction analysis
XRD patterns of the prepared calcium phosphate cements
(CPCs) were obtained at room temperature using a very highresolution Cu-Kα radiation diffraction system (Equinox3000, INEL,
Artenay, France) operating at a voltage of 40 kV and a current of
30 mA. CPCs were analyzed in the 2θ angle range of 0–80°, and their
patterns were studied to determine the crystal phases present in the
samples.

2.3.2. Fourier transform infrared spectroscopy (FTIR) analysis
Infrared spectroscopy was carried out to determine the chemical
composition of the prepared microspheres using FTIR (Nicolet, USA)
operating in the wavenumber range of 400–4000 cm− 1 at the
absorption mode.

2.3.3. Simultaneous thermal analysis
Simultaneous thermal analysis (STA) generally refers to the
simultaneous application of thermogravimetry (TGA) and differential
scanning calorimetry (DSC) to one and the same sample in a single
instrument. A thermoanalyzer (STA; Polymer Laboratories PL-STA
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1640) that was heated from room temperature up to ~ 1000 °C with
the warming rate of 10 °C/min was used to record the conventional
thermoanalytical curves.

2.3.4. Scanning electron microscopy (SEM)
The prepared microspheres were coated with a thin layer of gold
by sputtering (Emitech K450X, England). The microstructure of the
cement samples was observed using a scanning electron microscope
(AIS-2100 780, Seron, South Korea) that operated at an acceleration
voltage of 20 kV.

2.3.5. Setting time measurement
The powders of TTCP/DCPD were mixed with ratios of 1:1; and
then were mixed with liquid phase for a minute at room temperature.
Cement mixture was poured in a plastic mold to set. Setting time of
the prepared cement was measured using Vicat test according to the
ASTM-C-18798 standard.

2.3.6. Mechanical properties
In accordance with the ISO 14544, the modulus of the cements
was measured using a mechanical testing machine (SMT-20, Santam).
Cylindrical samples with length-to-diameter ratio of 2:1 (10 mm in
length and 5 mm in diameter) were prepared. The load was applied at
the cross-head speed of 1 mm/min until the specimen was compressed
to approximately 30% of its original length. The elastic modulus was
determined as the slope of the initial linear portion of the stress–strain
curve.

2.3.7. Inductively coupled plasma (ICP) analysis
The interactions between the cements and a biological medium
were carried out at 37 °C for 10, 20, and 110 days by immersing
about 10 mg of cement in a simulated body fluid, the composition of
which is almost identical to that of human plasma. These in vitro
assays were conducted under static conditions: biological fluids were
not renewed and therefore contained only limited amounts of P and
Ca. Inductively coupled plasma atomic emission spectroscopy (ICPMaterials Science and Engineering: C, Vol 69 (December 1, 2016): pg. 780-788. DOI. This article is © Elsevier and
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AES; Agilent, USA) was used to analyze the biological fluid before and
after cement interactions.

2.3.8. Biological evaluation
2.3.8.1. In vitro study
2.3.8.1.1. MTT assay
For measuring the cell viability of the prepared samples MTT (3(4, 5dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) assay
was used. At first, under standard culturing conditions SAOS-2 cells
were seeded on 96 well plates at a density of 1 × 104 cells per well.
The cells were incubated on the samples for 3 and 7 days. After the
incubation, the medium was removed and a medium containing 10%
of MTT solution was added. Then, the plates were incubated at 37 °C
for 4 h. The medium was then removed and 100 μl of solubilization
buffer (Triton-X 100, 0.1 N HCl and isopropanol) were added to each
well to dissolve the formazan crystals, which have been produced due
to the activity of living cells in MTT solution. The absorbance of the
lysate was measured in a microplate reader at a wavelength of
570 nm.
2.3.8.1.2. Alkaline phosphatase activity
Alkaline phosphatase (ALP) is an enzyme whose production
signifies proliferation and differentiation of osteoblasts. An ALP assay
kit was used to measure ALP activity according to the manufacturer's
protocol (Biocat, Heidelberg, Germany). Briefly, human osteosarcoma
cell lines (SAOS-2) were seeded in 24-well cell culture plates at a
density of 1 × 104 cells/cm2. The glass samples (n = 5) were placed in
the wells. Three wells in the absence of glass samples were used as
negative controls. The plates were incubated for 3 and 7 days at 37 °C
in humidified air with 5% CO2 with half media. Then, the supernatant
of each well was removed and the cell layer was rinsed twice with PBS,
homogenized with 1 ml Tris buffer, and sonicated for 4 min on ice.
Aliquots of 20 ml were incubated with 1 ml of a p-nitrophenyl
phosphate solution at 30 °C for up to 5 min. Cellular alkaline
phosphatase activity was determined by the conversion of pnitrophenyl phosphate to p-nitrophenol. It was monitored by following
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the absorption at 405 nm. It was converted to enzyme activity using
the p-nitrophenol standard absorption curve.
2.3.8.2. In vivo study
From the above in vitro experiments, the optimum powder-toliquid ratio for 3 wt% nanostrontium-enhanced CPC was determined as
0.83 which could provide the best setting time, and hence proper for
surgical procedures. This ratio was used for all the in vivo experiments
mentioned below, as well as for producing the composite of
nanostrontium-enhanced CPC with simvastatin-loaded poly(lactic-coglycolic acid) microspheres.
2.3.8.2.1. Animals, surgical procedures, and experimental grouping
The goal of this part was to comparatively evaluate the efficacy
of the produced material in bone morphogenesis. Ten 10-week-old
male Sprague–Dawley rats with an initial weight of 250–290 g were
purchased from the Pasteur Institute for the in vivo study. Animals
were anesthetized by means of intramuscular injection using ketamine
(80 mg/kg) and xylazine (10 mg/kg). A full-thickness incision was
made in the anterior region of the calvarium and a 5-mm diameter
full-thickness bone defect was prepared using a trephine drill under
continuous sterile saline irrigation. For the in vivo study, the prepared
calcium phosphate cement was implanted within the calvarium defect.
The defects were divided into control versus experimental groups: the
control group was CPC implanted in the defect on the left parietal
bone. The experimental defect was filled with nanostrontium-enhanced
CPC. Also, defects without implanted cements were made in the frontal
bone as negative controls. Soft tissues were sutured to achieve
primary closure. Four weeks after implantation, the animals were
sacrificed. The area of the original surgical defect and the surrounding
tissues were removed en bloc and fixed in 10% neutral buffered
formalin solution and then decalcified in 10% (v/v) nitric acid. Tissues
were embedded in a paraffin block and then serial sectioned using a
microtome to slides of approximately 4–6 μm thickness.

Materials Science and Engineering: C, Vol 69 (December 1, 2016): pg. 780-788. DOI. This article is © Elsevier and
permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission
for this article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.

11

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

2.3.8.2.2. Histological analysis and histomorphometry
Slides with tissue sections were de-paraffinized and hydrated
through series of xylene and alcohol. The tissue slides were stained
with hematoxylin & eosin (H&E) and observed under an optical
microscope for the histological observation (E400, Nikon, Tokyo,
Japan).
2.3.8.2.3. Radiographic examination
Radiographs were taken using an X-ray machine (Intra
Planmeca-Helsinki, Finland), after sacrificing. The percentage of bone
formation within the defects was evaluated blindly and independently
by two observers.

2.4. Preparation of the composite of simvastatin-loaded
poly(lactic-co-glycolic acid) (SIM-loaded PLGA)
microspheres plus nanostrontium-CPC
In order to create nanostrontium-CPC-incorporated simvastatinloaded poly(lactic-co-glycolic acid) (SIM-loaded PLGA), first, SIMloaded PLGA microspheres were produced. The production and
evaluation of SIM-loaded PLGA microspheres [without CPC
composition] including their simvastatin release kinetics are reported
in another article.34 Briefly put, they were prepared by oil-in-water
(O/W) emulsion/solvent evaporation method under magnetic stirrer,
and later by centrifuging, and 24 h of freeze drying.34 Then 3 wt%
nanostrontium-CPC was produced as explained above (0.5 g of TTCP
with a controlled mean particle size of 10 μm was synthesized and
blended with 0.5 g of DCPD, and 3 wt% of synthesized nanostrontiumsubstituted hydroxyapatite). Afterwards, 0.1 g of SIM-loaded PLGA
microspheres was added to the powder cement. Subsequently, for
setting of the cement, 1.205 ml (Powder/Liquid = 0.83) of disodium
hydrogen phosphate (Na2HPO4; Merck) was added to the mixture. The
‘SIM-loaded PLGA microspheres + nanostrontium-CPC’ composite was
vacuum-packed and g-ray-sterilized (20 kGy).
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2.5. Characterization of the composite of SIM-loaded
PLGA microspheres and nanostrontium-CPC
2.5.1. SEM
The composite was scanned as described above.

2.5.2. In vivo evaluations
The efficacy of the produced composite in osteogenesis
induction was compared with other biomaterials (3 wt%
nanostrontium-enhanced CPC, and 3 wt% nanostrontium-enhanced
CPC plus simvastatin) and control groups.
2.5.2.1. Animals, surgical procedures, and experimental groups
Ten mature, male New Zealand white rabbits, with an average
weight of 3.5 kg, were purchased from the Pasteur Institute. Each
rabbit was housed in an individual cage, in Iranian Tissue Bank and
Research, Tehran, Iran. Food and water were available ad libitum.
Prophylactic antibiotic (gentamicin 6 mg/kg) was administered 3 h
before surgery. The animals were anesthetized with injection of
ketamine at a dosage of 40 mg/kg IM (ketamine hydrochloride,
Trittau, Germany, Rotexmedica) and Xylazine at a dosage of 5 mg/kg
IM (Xylazine 2%, Alfasan-woerden-Holland). During the surgery,
lidocaine hydrochloride was locally administered. After shaving and
disinfecting the surgical site with 10% pivodine iodine, skin incision
was made in dorsal part of the cranium. Then, periosteum was flapped
carefully and parietal bone was exposed. Full thickness bone defects,
8 mm in diameter, were parallel trephined in the parietal bone without
damaging the dura (trephine height was about the width of the bone).
An 8-mm Trephine bur (rotary motor, W&H, Austria) was used to
create the defects, under constant irrigation with sterile normal saline
to prevent overheating of the bone margins.
In each animal, 5 sites were prepared: a negative control, which
was a defect left empty after trephining the bone. A positive control,
which was an experimentally made defect, filled with the bone
trephined from the site of the negative control. A third defect filled
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with “SIM-loaded PLGA + nanostrontium-enhanced CPC” composite. A
fourth defect filled with 3 wt% nanostrontium-enhanced CPC. And a
fifth defect filled with a combination of 3 wt% nanostrontiumenhanced CPC plus simvastatin. The coordinates of defect areas were
scaled and noted down.
Afterwards, the periosteum and muscles were carefully
repositioned on the outer surface of the implants and sutured in place
using catgut 3-0. Afterwards, the skin was sutured with silk 2-0. After
the surgery, the rabbits were housed with free access to water and
food. Injection with Enrofloxacin 5 mg/kg (Enro-10%, Maghull,
Liverpool, UK) was given every 12 h, for 48 h, post-operation. All the
experiments and protocols described in the present study were
performed in accordance with the guidelines for the care and use of
laboratory animals.
2.5.2.2. Histological study and histomorphometry
Animals were euthanized 8 weeks after surgery by vital
perfusion, with the intravenous injection of pentobarbital. Defect areas
were separated and fixed in 10% formalin for 48 h. Samples were
decalcified by 10% formic acid for 30 days, dehydrated in ethanol, and
then embedded in 10 × 10-mm paraffin blocks. Samples were then cut
into serial 4 μm sections. Three sections from the central area of each
defect were selected, stained with H&E, and subjected to
histomorphometric analysis. Bone formation was observed under a
Nikon light microscope (E400, Tokyo, Japan) at magnification × 400,
and analyzed using computerized image processing software.

2.6. Statistical analysis
Data values obtained in the experiments were statistically
analyzed by one-way analysis of variance (ANOVA) and Tukey post hoc
test. The level of significance was set at 0.05.

3. Results and discussion
Bone defect caused by tumor, trauma and other diseases can
often be repaired by bone graft. However, its clinical application is
limited due to a second surgical site for access to retrieved graft and
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other complications for autogenous bone graft as well as the limited
availability, rejection and the spread of disease for allograft. With the
development of material and biological science, bone tissue
engineering provides a new method to restore the tissue loss or
failure, which aims to develop biological substitutes to repair and
improve the function of the organization. The basic requirements for
an ideal scaffold for bone tissue engineering include several factors as
follows.35,36,37,38 Good biocompatibility: In addition to meet the nontoxic, non-teratogenic and other general requirements, it should be
also conducive to the cell adhesion and proliferation, and its
degradation products should have no adverse effects on the cell
adhesion, growth and differentiation. Good biodegradability: Scaffold
material should be degraded after completion of its supporting role,
and the degradation should be adapted to the formation of bone
tissue, thus contributing to the reconstruction of bone. A 3D porous
structure: This structure not only provides a large surface area and
space, which is conducive to the growth of cell adhesion, extracellular
matrix deposition, nutrients infiltration and metabolite discharge, but
also promotes the ingrowth of blood vessels and nerves. Moldability
and relatively high mechanical strength: Scaffold material should be
formed into a certain shape with a certain mechanical strength, which
provides mechanical support for the new tissue and allows for weight
bearing. Good osteoconductivity and osteoinductivity: Scaffolds should
have surface chemical properties and microstructure to support the
bone cell growth and migration.35,36,37,38

3.1. Results and discussions pertaining to the
nanostrontium-enhanced CPC
3.1.1. XRD analysis
According to diffraction patterns of the prepared samples, TTCP
and HA peaks were observed between 0° ≤ 2θ ≤ 80° with no
additional phases such as CaO, perhaps because TTCP was obtained by
means of quenching method at 1500 °C after 12 h instead of furnacecooled method (which might result in production of TTCP, HA and free
CaO from decomposition of TTCP).39 As a result, the optimum process
to obtain the high contents of TTCP and remove CaO phase is a
quenching after holding 12 h. In additional, it can be concluded that all
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the DCPD has transformed into HA in the synthesized cement (Fig. 2).
The proportion of powder to liquid is a significant feature of cements
as it can affect both bioresorbability and rheological properties.40
According to the Fig. 2, it seems that by increasing the ratio of
Powder/Liquid, crystallinity of the prepared cement might also
increase. This might imply an increase in crystallinity of HA in
comparison with apatite cements formed in an aqueous environment,
which have poorer crystalline HA as the end product.40 The substitution
of calcium with strontium can alter the crystal structure; this is visible
in Fig. 2 as well-defined and sharp peaks in association with
incorporation of Sr ions. This is in agreement with a high degree of
crystallinity of cement reported earlier.41,42 On the other hand, the
broadening is more obvious for the samples with smaller amounts of
strontium because there exists a greater difficulty for HA to host the
larger Sr ion than for HA-containing Sr to host the smaller calcium ion
with respect to their ionic radii (Ca2 + ionic radius = 0.100 nm; Sr2 +
ionic radius = 0.118 nm).41 Additionally, a shift of diffraction peaks to
lower 2θ values with Sr addition was observed; which this might
indicate a gradual increase in d-spacing.42 Meanwhile, in the samples
with no strontium hydroxyapatite (Sr-HA), no significant increase in
crystallinity was observed.

Fig. 2. XRD pattern of CPC and Sr-HA-CPC with different P/L ratios. At 2θ = 0, all the
six lines start at zero on the vertical axis. Three P/L ratios have been artificially
separated by adding 200 and 400 units to the ratios 1.25 and 1.55, respectively. For
each P/L ratio, the results pertaining to CPC and Sr-HA-CPC are overlapped
intentionally. Violet circles mark hydroxyapatite. Red circles indicate both
hydroxyapatite and tetracalcium phosphate.
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3.1.2. FTIR analysis
In Fig. 3, FTIR spectra of the CPC (prepared with and without
3 wt% Sr-HA of different P/L ratios (0.83, 1.25, and 1.55)) are
exhibited. There was no considerable difference between CPC with and
without strontium. Analyses of the spectra are as follows: FTIR spectra
of the three samples follow a single model. The FTIR analysis
determines the functional groups of the samples; since the functional
groups are similar in all three prepared cements, FTIR similarity is
expected. The bands in the range of 3488 to 3497 cm− 1 spectral of the
three types of cements are related to vibration of adsorbed water and
presence of hydroxyl groups. Incorporation of Sr ion instead of Ca
decreases the relative intensity of the bands of OH– stretching. In this
case vibration modes as well as OH– stretching mode shift to high
wave numbers, while OH– liberation band shifts to lower wave
numbers, in agreement with results reported for Ca-HA and Sr-HA.43
The bands 1640 to 1643 cm− 1 are related to absorption of H2O. The
bands at 512–517 cm− 1, 520–530 cm− 1 and 1010–1034 cm− 1 are
related to V2PO4− 3, V3PO4− 3, and V1PO4− 3 respectively that could be
due to presence of calcium phosphate compounds (TTCP, DCPD and
HA) in the samples. FTIR results of Bigi et al.41 pertaining to pure CaHA showed that phosphate groups shift to lower wave numbers with
incorporation of Sr ions and formation Sr-HA. The predominant factor
causing the shift in the internal PO4 frequencies to lower energies is
the reduced anion-anion repulsion concomitant with an increased
anion-anion separation on increasing cation radius. The influence of Sr
in shifting phosphate group is attributed to the increasing average
dimensions of the cation,41 and indicates an increase of irregularity in
the HA structure around phosphate sites through the incorporation of
Sr. These bands can also be related to formation of hydroxyapatite by
the reaction happening between the liquid and powder phases of the
cement. The observed bands at 883–881 cm− 1 are related to
carbonate groups; this might imply the absorption of carbonate from
the environment.
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Fig. 3. FTIR spectra of prepared CPC (A) and Sr-HA-CPC (B) with different P/L ratios.
1: V2PO4− 3, 2: carbonate; 3: V1PO4− 3, 4: water; 5: OH.

3.1.3. Thermal analysis
Four phases were observed in thermal analysis. In the first
phase (up to 280 °C), the surface humidity is absorbed. The weight
reduction of the samples begins at 25 to 280 °C during which about
1 mg of weight is lost, probably as a result of water evaporation. In
the second phase, the sample experienced a slight weight loss (about
0.1 mg) in the temperature range of about 280 to 375 °C which can be
related to the crystallization of the powders from the amorphous.44 The
third stage (375 to 550 °C) showed about 0.5 mg weight loss, and
might be related to reduction of hydroxyl groups with decomposition of
HPO4− 2 anions to pyrophosphate anions P2O7− 4. The fourth stage
(about 2.3 mg weight loss at 550 to 880 °C temperatures) might be
attributed to the release of CO2 gas during endothermic decomposition
of CO3− 2 and/or decomposition of pyrophosphates to biphasic mixtures
[as in P2O74− → 2PO43− + H2O].45
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3.1.4. SEM observations
The SEM micrographs of CPC and Sr-HA-CPC (Fig. 4) indicate
that with increasing the P/L ratio, the formation of hydroxyapatite
crystals (arising from the interaction of solid and liquid phases) might
decrease. The incorporation of Sr within Ca site causes a dramatic
increase in crystallinity of hydroxyapatite. Strontium atoms can occupy
both M(1) and M(2) sites of the apatite structure, depending on the
amount of strontium. At very low Sr contents, the occupancy of M(1)
is more probable, while samples containing > 10 atom% Sr
demonstrated a preferential Sr occupancy at M(2) sites.41 The M(2)
sites allow a better accommodation of the bigger Sr atoms; whereas in
the M(1) sites, metals are hardly aligned in columns parallel to the caxis. Perhaps, longer average M(1)-O distances might allow the
accommodation of a larger cation. With increase of the number of
bigger ions, the repulsion between atoms in the M(1) site might trigger
an enlargement of the c-axis. Furthermore, the greater extent of Sr
distribution might cause a significant discontinuity in the cell
parameter variation.46 It was also reported that within each specific Sr
occupancy, the relationship between the excess energies Ex of the solid
solution Sr-HA-X structures and sites for substitution of Sr is Ex site
(1) < Ex mixed sites < Ex site (2). Hence, Sr incorporation at site 1 is
more favorable than at mixed sites followed by site 2.47

Fig. 4. SEM micrographs of prepared CPC without 3 wt% Sr-HA (A to C) and with
3 wt% Sr-HA (D to F). The P/L ratios are 0.83, 1.25 and 1.55, from left to right (i.e.,
from A to C, and from D to F).
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3.1.5. Setting time
With an increase in the powder-to-liquid ratio of 3 wt% Sr-HACPC, the setting time might reduce (Table 1). The relative solubility of
phases of TTCP and DCPD is regarded as a major factor affecting the
setting time of calcium phosphate. HA was precipitated according to
the following equation: 2Ca4(PO)2O + 2CaHPO4 → Ca10(PO4)6 (OH)2.
Table 1. Setting time of the prepared CPC with 3 wt% Sr-HA with different
P/L ratio.
P/L ratio Setting time (min)
0.83

28.7±0.4

1.25

9.3±0.1

1.55

2.2±0.2

Applying Na2HPO4 (as a liquid phase) to prepare the cement
increases the rate of hydroxyapatite formation and decreases the
setting time. In other words, lower powder-to-liquid ratios might
elongate the working and setting time of the mass, delaying the
supersaturation of hydrate phases (i.e., hydroxyapatite In apatite
cements).48

3.1.6. ICP analysis
The release of strontium after interaction in the Sr-free medium
is presented for cement samples in Table 2. This might be useful for
osteoporosis therapy.49,50 The smooth delivery of Sr2 + ions in biological
conditions might be attributed to the substitution of Ca for Sr in the
Sr-enhanced cements.49,51 After this interaction, some strontium
remains in the hydroxyapatite and might serve as a reservoir for
future osseointegration of implants upon bone re-modeling.49,51
Table 2. Release of Sr, Ca and P ions as a function of interaction time for
cement samples (P value < 0.01).
Days Ca (ppm)

P (ppm)

Sr (ppm)

10

39.6±4.7

60.9±3.6

0.1

20

62.8±8.9

70.2±7.7

0.3±0.1

110 138.6±13.4 121.8±15.8 0.8±0.1
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3.1.7. Mechanical properties
Mechanical properties of the cement are given in Fig. 5.
Although the ceramic samples behaved similar to other ceramic bone
cements but their mechanical properties were smaller compared to
their corresponding values in spongy and compact bone.

Fig. 5. Mechanical properties of the prepared cement. The final amounts of the
Young's modulus and ultimate strength are 33.06 ± 2.06 and 2.24 ± 0.12 MPa,
respectively.
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3.1.8. Biological evaluations
3.1.8.1. In vitro study
3.1.8.1.1. MTT assay
Cytocompatibility of the prepared cements was assessed using
MTT assay (Fig. 6). After 14 days of incubation, the cell viability
decreased for all samples, whereas, the reduction was insignificant for
all of them. Addition of 3 wt% of nanostrontium hydroxyapatite (SrHA) increased the biocompatibility of the prepared cements
(P < 0.05). The prepared cements have proper biocompatibility and
are suitable for use as bone cement. It has been proved that Sr ions
can stimulate cellular responses. The influence of strontium ions on
viability of osteoblastic cells might be dose-dependent, owing to the
lower viability rate of the osteoblasts on calcium phosphate cements
compared with their viability on other Sr-hydroxyapatite cements. In
agreement with other studies, our findings as well indicated that the
incorporation of Sr in hydroxyapatite cement might encourage new
bone formation.42,52 Although, it is known that Sr incorporation
enhances cell proliferation, its optimum concentration is still
controversial. Park et al.53 found that Sr ions release at 103–135 ppb
increased the differentiation of osteoblast. Also, other results suggest
that Sr alone at concentrations between 1.21 and 3.24 does not
impact the proliferation of osteoblast cells.42

Fig. 6. Cell proliferation of SAOS-2 cells proliferated on the CPC with and without
3 wt% Sr-HA with different P/L ratios along with negative control after incubation for
7, and 14 days.
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3.1.8.1.2. Alkaline phosphatase
Measurement of ALP activity is considered one of the criteria
necessary for osteoblast activity. Fig. 7 shows the results of the ALP
activity of different prepared cements after 3 and 7 days of incubation,
indicating a significant increase in ALP activity by adding Sr-HA
(P < 0.05). This might be attributed to the presence of strontium ions
which might increase the activity of bone cells. The cements with P/L
ratio of 1.25 had the highest level of alkaline phosphatase activity
compared to P/L ratios of 1.55 and 0.83. Therefore, the P/L ratio of
1.25 was selected as the optimum ratio in CPC. It is noteworthy that
the biology activity of Sr-containing cement is also attributed to the
influences on crystallinity and expansion of its crystal lattice due to the
larger size of Sr compared to Ca. In addition, according to the SEM
analysis (Fig. 4), the samples containing Sr consisted of larger,
needle-like crystals. As a result, the small tightly entangled crystal can
provide more nucleation sites for the formation of apatite crystals.54,55

Fig. 7. ALP activity test for SAOS-2 cells proliferated on the CPC with and without
3 wt% Sr-HA with different P/L ratio along with negative control after incubation for 7
and 14 days (P > 0.05).
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3.1.8.2. In vivo study
3.1.8.2.1. Histological analysis and histomorphometry
The in vivo bone tissue response towards three samples was
evaluated by means of histological examination, after surgical
placement of the materials “3 wt% Sr-HA/CPC”, “CPC” and the control
in rat for 4 weeks (Fig. 8). After 4 week post-implantation, no severe
inflammation, tissue necrosis or tissue rejection was observed.
Generally, fibrous connective tissue and blood vessels grow into the
macropores, contributing to the early fixation of the samples.

Fig. 8. Implantation steps in rat (the frontal socket is negative control).

CPC gradually dissolves in the body and releases calcium and
phosphate ions.56 The histomorphometric analysis in this study
displayed an increase in the bone formation for the Sr-CPC (ANOVA's
P < 0.05) in comparison with the defect areas filled with CPC without
Sr and the negative control (empty defect). It should also be noted
that the formation of bone at both the periphery and center of fracture
defect area for all the samples were visible. This can be attributed to
the local release of Sr from cement that might improve osteogenesis.
Molecular-biological activities (enhanced expression of BMP2,
osteocalcin and OPG) were observed in this study indicating an
increased formation of new bone in Sr-containing cement in
comparison with CPC and the negative control. Furthermore, it is
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possible that strontium's osteogenic activity preserved within the
cement.25,57 The uptake of strontium by the bone may increase the
bone volume by increasing the sites of bone formation and decreasing
bone resorption, without affecting the rate of osteogenesis and bone
mineralization.54
3.1.8.2.2. Radiographic analysis
Strontium-containing cement is inherently radiopaque without a
need to additional materials for radio-examination. No inflammatory
response and no necrosis were found in the rats implanted with Sr-HA
cement. The similarity of minerals in Sr-HA cement and bone promotes
the fusion of the material to the bone during osteogenesis. As a
consequence, Sr-HA bioactive cement might have the potential to be
utilized to treat osteoporotic fractures.58

3.2. Results and discussions pertaining to the
composition of SIM-loaded PLGA
microspheres + nanostrontium-enhanced CPC
3.2.1. SEM observations
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The SIM-PLGA + Sr-PC scaffold possessed suitable pore sizes
and interconnected pores (Fig. 9).
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Fig. 9. SEM micrographs of cement containing SIM-loaded PLGA.

3.2.2. In vivo evaluations
The surgical steps for rabbit are presented in Fig. 10. After
8 weeks of in vivo application, only a small amount of bone had been
regenerated in the control group (Fig. 11). This newly formed bone
was only localized at the boundary of the defect, and the defects were
mostly filled with soft tissue. On the other hand, the other groups
showed new bone formation within the bone cements filling the defect.
The new bone area for the control group was significantly lower than
the other groups (Tukey's P < 0.01). A significant difference was found
in the osteogenesis induced by the groups sham (negative) control
(16.96 ± 1.01), bone materials (positive control) (32.28 ± 4.03),
nanostrontium-CPC (24.84 ± 2.6), nanostrontium-CPC-simvastatin
(40.12 ± 3.29), and SIM-loaded PLGA + nanostrontium-CPC
(44.8 ± 6.45) (ANOVA's P < 0.001). All the pairwise comparisons were
significant (Tukey's P < 0.01), except that of nanostrontium-CPCsimvastatin and SIM-loaded PLGA + nanostrontium-CPC. This
confirmed the efficacy of the SIM-loaded PLGA + nanostrontium-CPC
composite, and its superiority over all materials except SIM-containing
nanostrontium-CPC (Table 3). SIM is widely used in clinical lipidlowering drugs, and its osteogenic potential for bone metabolism has
become a hot research field in recent years.28,32,33 SIM plays a role in
promoting new bone formation and regulation, which is related to
BMP-2 and VEGF expression of osteoblasts.21,22 In our study, we found
the scaffolds co-cultured with BMSCs in vitro improved the cell
proliferation and significantly induced osteogenic differentiation, thus
promoting the ALP activity and enhancing their osteogenic capability.
Drug utilization rate of systemic administration is limited due to its
potential systemic side effects. Topical administration makes a higher
drug concentration at the bone defect site, leading to suppressed drug
utilization rate.23 The results of the in vivo experiments showed that
the pure CPC group had the least new bone formation area at 8 weeks
after implantation. However, the new bone formation area of SIMloaded group was significantly higher than other groups, indicating
that of topical administration in vivo and satisfactory osteogenic effect
could be obtained through the application of SIM-PLGA + Sr-CPC
scaffold. Pore size and porosity of the scaffold are important conditions
for ingrowth of new bone tissue, and it is desirable to provide a
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suitable pore space for the bone formation, vascular ingrowth and
deposition of extracellular matrix. Osteoblast migration requires a
minimum pore size of 100 μm, whereas a suitable fibroblast growing
space is 180–300 μm.24,25 Therefore, in order to provide the most basic
environment of osteoblast growth, the pore size of scaffolds should be
around 200 μm. However, only a suitable pore size is not enough for
porous scaffold material.26 It is difficult to cause the new bone to grow
inside the scaffold if the connection between the porosity is not
sufficient. The interconnected micropores on the pore walls of
macropores are conducive to new blood vessels to grow deeper into
the scaffold, to supply nutrients and discharge metabolites, which is
beneficial to the new bone formation. In the present study, in vitro
methods were adopted to test the response of BMSCs to the SIMPLGA + Sr-CPC scaffold. The results suggested that SIM-PLGA + SrCPC scaffolds promoted a higher degree of osteogenic differentiation
compared with pure scaffolds. It also indirectly indicated that SIM
could play a role in promoting the osteogenic differentiation of BMSCs.
During our investigation, all rabbits were under good health and did
not show any surgery complications. At 8 weeks, the implanted SIMPLGA + Sr-CPC scaffolds and tissue cells exhibited good
biocompatibility. Radiographic and histological investigations were
performed to assess the process of bone tissue formation.

Fig. 10. The surgical steps in rabbit (the first row), and the outcome (the second
row).
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Fig. 11. Histological images at 8 weeks, (a) no augmentation (control group; ctrl), (b)
bone materials (BM), (c) Sr-CPC (C), and (d) Sr-CPC containing SIM (CS) and (e) SrCPC containing SIM loaded PLGA microsphere (CPS).

Table 3. New bone formation (%) in rabbit.
Groups

Mean SD

95% CI

Negative control

16.96 1.01 16.33

17.59

Bone materials

32.28 4.03 29.78

34.78

Sr-CPC

24.84 2.60 23.23

26.45

Sr-CPC+SIM

40.12 3.29 38.08

42.16

Sr-CPC-SIM-PLGA 44.80 6.45 40.80

48.80
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This study also had limitations. Young animals have better
physical condition as well as more resistance to operation compared to
old ones. Therefore, only young animals were included. This may limit
the clinical relevance of the results. Moreover, it was better to test a
broader range of powder-to-liquid ratios, in order to identify the
optimized ratio with a greater confidence. In addition, SEM
interpretation is subjective and prone to bias.

4. Conclusions
4.1. Nanostrontium-enhanced CPC
In conclusion, XRD analysis demonstrated that by increasing the
ratio of powder-to-liquid, crystallinity of the prepared cement
increases. The substitution of calcium by strontium in CPC can alters
the crystal structure. According to the SEM observations, by increasing
the P/L ratio of CPC, the formation of hydroxyapatite crystals arising
from the interaction of solid and liquid phase of cement will be
reduced. Sr-CPC has better ALP activity and biocompatibility (indicated
by MTT assay) and induced higher bone regeneration.

4.2. SIM-loaded PLGA microspheres + nanostrontiumenhanced CPC
The prepared composite exhibited a good interconnective pore
structure for cell seeding and transplantation. Sr-CPC containing
simvastatin-loaded PLGA microsphere demonstrated a higher level of
osteogenic differentiation.
The key findings of this study can be summarized as follows.
The addition of nanostrontium can enhance the chemophysical
properties of CPC and increase the crystallinity of hydroxyapatite while
being cytocompatible and encouraging osteogenesis without inducing
inflammatory responses or other disturbances for the tissue. Higher
P/L ratios of nano-Sr-CPC might improve the chemomechanical
properties and reduce the setting time. The composition of nano-SrCPC with PLGA microsphere loaded with simvastatin creates a porous
material that can boost the osteogenesis about twice compared to the
osteogenesis induced by nano-Sr-CPC.
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